The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Zoster sine herpete: a review

  • Zhou, Junli (Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University) ;
  • Li, Juan (Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University) ;
  • Ma, Lulin (Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University) ;
  • Cao, Song (Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University)
  • Received : 2020.04.06
  • Accepted : 2020.06.02
  • Published : 2020.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Zoster sine herpete (ZSH) is one of the atypical clinical manifestations of herpes zoster (HZ), which stems from infection and reactivation of the varicella-zoster virus (VZV) in the cranial nerve, spinal nerve, viscera, or autonomic nerve. Patients with ZSH display variable symptoms, such as neuralgia, however, different from HZ, ZSH show no zoster, which makes clinical diagnosis difficult. ZSH not only causes initial symptoms, such as neuropathic pain in the affected nerve, Bell palsy, and Ramsay Hunt syndrome, but also postherpetic neuralgia and fatal complications such as VZV encephalitis and stroke. The misdiagnosis of ZSH and tardy antiviral treatment may lead to severe ZSH sequelae. We review the publications related to ZSH, especially its diagnosis with VZV DNA and/or anti-VZV immunoglobulin (IgG and IgM). More work about ZSH, especially ZSH epidemiological survey and guidelines for its diagnosis and treatment, are needed because most of the present studies are case reports.

Keywords

References

  1. Dayan RR, Peleg R. Herpes zoster - typical and atypical presentations. Postgrad Med 2017; 129: 567-71. https://doi.org/10.1080/00325481.2017.1335574
  2. Nagel MA, Gilden DH. The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med 2007; 74: 489-94, 496, 498-9 passim. https://doi.org/10.3949/ccjm.74.7.489
  3. Kennedy PGE, Gershon AA. Clinical features of varicellazoster virus infection. Viruses 2018; 10: 609. https://doi.org/10.3390/v10110609
  4. Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain 2015; 28: 177-84. https://doi.org/10.3344/kjp.2015.28.3.177
  5. Lewis GW. Zoster sine herpete. Br Med J 1958; 2: 418-21. https://doi.org/10.1136/bmj.2.5093.418
  6. Drago F, Herzum A, Ciccarese G, Broccolo F, Rebora A, Parodi A. Acute pain and postherpetic neuralgia related to varicella zoster virus reactivation: comparison between typical herpes zoster and zoster sine herpete. J Med Virol 2019; 91: 287-95. https://doi.org/10.1002/jmv.25304
  7. Ibraheem M, Marin M, Leung J, Bryce CH, Schmid DS, Zaki SR, et al. Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child. Pediatr Infect Dis J 2013; 32: 183-5. https://doi.org/10.1097/inf.0b013e318273e43d
  8. Chen WH, Chui C, Yin HL. Zoster sine herpete, vertebral artery stenosis, and ischemic stroke. J Stroke Cerebrovasc Dis 2013; 22: e234-7. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.07.017
  9. Weaver BA. Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc 2009; 109(6 Suppl 2): S2-6.
  10. Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a communitybased prospective cohort study: the SHEZ study. J Epidemiol 2015; 25: 617-25. https://doi.org/10.2188/jea.JE20140210
  11. Yang F, Yu S, Fan B, Liu Y, Chen YX, Kudel I, et al. The epidemiology of herpes zoster and postherpetic neuralgia in China: results from a cross-sectional study. Pain Ther 2019; 8: 249-59. https://doi.org/10.1007/s40122-019-0127-z
  12. Tseng HF, Bruxvoort K, Ackerson B, Luo Y, Tanenbaum H, Tian Y, et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ${\geq}$50 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis 2019. doi: 10.1093/infdis/jiz652.
  13. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med 2014; 371: 1526-33. https://doi.org/10.1056/NEJMcp1403062
  14. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014; 4: e004833. https://doi.org/10.1136/bmjopen-2014-004833
  15. Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a populationbased study. Clin Infect Dis 2016; 63: 221-6. https://doi.org/10.1093/cid/ciw296
  16. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48(Suppl 1): S2-7. https://doi.org/10.1016/S1386-6532(10)70002-0
  17. Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol 2018; 84: 251-62. https://doi.org/10.4103/ijdvl.ijdvl_1021_16
  18. Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis 2016; 35: 723-34. https://doi.org/10.1007/s10096-016-2605-0
  19. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Primers 2015; 1: 15016. https://doi.org/10.1038/nrdp.2015.16
  20. McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009; 48: 1364-71. https://doi.org/10.1086/598331
  21. Laemmle L, Goldstein RS, Kinchington PR. Modeling varicella zoster virus persistence and reactivation - closer to resolving a perplexing persistent state. Front Microbiol 2019; 10: 1634. https://doi.org/10.3389/fmicb.2019.01634
  22. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266-7. https://doi.org/10.1056/NEJMp058091
  23. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Tolllike receptor 2. J Virol 2005; 79: 12658-66. https://doi.org/10.1128/JVI.79.20.12658-12666.2005
  24. Hevner R, Vilela M, Rostomily R, Cohrs R, Mahalingam R, Wellish M, et al. An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol 2003; 2: 567-71. https://doi.org/10.1016/S1474-4422(03)00506-4
  25. Birlea M, Nagel MA, Khmeleva N, Choe A, Kleinschmidt-Demasters B, Hevner R, et al. Varicella-zoster virus trigeminal ganglioneuritis without rash. Neurology 2014; 82: 90-2. https://doi.org/10.1212/01.wnl.0000438228.48470.86
  26. Zerboni L, Arvin A. Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo. PLoS Pathog 2015; 11: e1004989. https://doi.org/10.1371/journal.ppat.1004989
  27. Furuta Y, Fukuda S, Suzuki S, Takasu T, Inuyama Y, Nagashima K. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol 1997; 52: 316-9. https://doi.org/10.1002/(SICI)1096-9071(199707)52:3<316::AID-JMV13>3.0.CO;2-G
  28. Gershon AA, Gershon MD. The Jeremiah Metzger lecture varicella zoster virus: from outside to inside. Trans Am Clin Climatol Assoc 2016; 127: 282-99.
  29. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010; 342: 243-53.
  30. Galetta KM, Gilden D. Zeroing in on zoster: a tale of many disorders produced by one virus. J Neurol Sci 2015; 358: 38-45. https://doi.org/10.1016/j.jns.2015.10.004
  31. Kennedy PG. Zoster sine herpete: it would be rash to ignore it. Neurology 2011; 76: 416-7. https://doi.org/10.1212/WNL.0b013e31820a0d5d
  32. Edelman DA, Antaki F, Basson MD, Salwen WA, Gruber SA, Losanoff JE. Ogilvie syndrome and herpes zoster: case report and review of the literature. J Emerg Med 2010; 39: 696-700. https://doi.org/10.1016/j.jemermed.2009.02.010
  33. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994; 35: 530-3. https://doi.org/10.1002/ana.410350505
  34. Kasahara M, Ichinohe T, Sano T, Fukuda K, Kaneko Y. A case of zoster sine herpete of the trigeminal nerve. Bull Tokyo Dent Coll 2011; 52: 47-51. https://doi.org/10.2209/tdcpublication.52.47
  35. Hosseini S, Zawawi F, Young J. Atypical presentation of a common disease: shingles of the larynx. J Voice 2015; 29: 600-2. https://doi.org/10.1016/j.jvoice.2014.10.010
  36. Sengoku R, Yaguchi H, Matsushima S, Mochio S. Zoster sine herpete: detection by skin exudates and contrast magnetic resonance imaging. Eur Neurol 2012; 67: 154. https://doi.org/10.1159/000334924
  37. Silverstein BE, Chandler D, Neger R, Margolis TP. Disciform keratitis: a case of herpes zoster sine herpete. Am J Ophthalmol 1997; 123: 254-5. https://doi.org/10.1016/S0002-9394(14)71044-X
  38. Gershon AA, Chen J, Gershon MD. Use of saliva to identify varicella zoster virus infection of the gut. Clin Infect Dis 2015; 61: 536-44. https://doi.org/10.1093/cid/civ320
  39. Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev 2013; 26: 728-43. https://doi.org/10.1128/CMR.00052-13
  40. Leung J, Harpaz R, Baughman AL, Heath K, Loparev V, Vazquez M, et al. Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis 2010; 51: 23-32. https://doi.org/10.1086/653113
  41. Quinlivan M, Sengupta N, Papaevangelou V, Sauerbrei A, Grillner L, Rousseva R, et al. Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe. J Infect Dis 2013; 207: 588-93. https://doi.org/10.1093/infdis/jis649
  42. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 2011; 203: 316-23. https://doi.org/10.1093/infdis/jiq066
  43. Papaevangelou V, Quinlivan M, Lockwood J, Papaloukas O, Sideri G, Critselis E, et al. Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clin Microbiol Infect 2013; 19: E245-51.
  44. Tecellioglu M, Kamisli S, Erbay MF, Kamisli O, Ozcan C. A rare presentation of cranial polyneuropathy without rash caused by varicella zoster virus. Med Arch 2017; 71: 293-5. https://doi.org/10.5455/medarh.2017.71.293-295
  45. Gershon AA. The history and mystery of VZV in saliva. J Infect Dis 2011; 204: 815-6. https://doi.org/10.1093/infdis/jir417
  46. Park SY, Kim JY, Kwon JS, Jeon NY, Kim MC, Chong YP, et al. Relationships of varicella zoster virus (VZV)-specific cellmediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. J Med Virol 2019; 91: 1995-2000. https://doi.org/10.1002/jmv.25543
  47. Nahass GT, Penneys NS, Leonardi CL. The clinical spectrum from classic varicella zoster to zoster sine herpete: the missing link. Arch Dermatol 1992; 128: 1278-9.
  48. Easton HG. Zoster sine herpete causing acute trigeminal neuralgia. Lancet 1970; 2: 1065-6. https://doi.org/10.1016/S0140-6736(70)90291-6
  49. Nagel MA, Gilden D. Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol 2014; 27: 356-60. https://doi.org/10.1097/WCO.0000000000000092
  50. Vena GA, Apruzzi D, Vestita M, Calvario A, Foti C, Cassano N. Zoster ... "almost" ... sine herpete: diagnostic utility of real time-polymerase chain reaction. New Microbiol 2010; 33: 409-10.
  51. Lee HY, Kim MG, Park DC, Park MS, Byun JY, Yeo SG. Zoster sine herpete causing facial palsy. Am J Otolaryngol 2012; 33: 565-71. https://doi.org/10.1016/j.amjoto.2012.02.001
  52. Furuta Y, Ohtani F, Mesuda Y, Fukuda S, Inuyama Y. Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology 2000; 55: 708-10. https://doi.org/10.1212/WNL.55.5.708
  53. Tamir B, Peleg R. Burning pain from chest to back.allodynia and hyperesthesia.extreme sensitivity at the left T5 dermatome.Dx? J Fam Pract 2015; 64: E1-2.
  54. Morita Y, Osaki Y, Doi Y, Forghani B, Gilden DH. Chronic active VZV infection manifesting as zoster sine herpete, zoster paresis and myelopathy. J Neurol Sci 2003; 212: 7-9. https://doi.org/10.1016/S0022-510X(03)00081-9
  55. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007; 68: 1069-73. https://doi.org/10.1212/01.wnl.0000258549.13334.16
  56. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: case report and review of the literature. J Neurol Sci 2010; 292: 85-8. https://doi.org/10.1016/j.jns.2010.01.019
  57. Gilden D, Nagel MA, Ransohoff RM, Cohrs RJ, Mahalingam R, Tanabe JL. Recurrent varicella zoster virus myelopathy. J Neurol Sci 2009; 276: 196-8. https://doi.org/10.1016/j.jns.2008.09.025
  58. Blumenthal DT, Shacham-Shmueli E, Bokstein F, Schmid DS, Cohrs RJ, Nagel MA, et al. Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF. Neurology 2011; 76: 484-5. https://doi.org/10.1212/WNL.0b013e31820a0d28
  59. Amlie-Lefond C, Mackin GA, Ferguson M, Wright RR, Mahalingam R, Gilden DH. Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol 1996; 2: 136-8. https://doi.org/10.3109/13550289609146547
  60. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-45. https://doi.org/10.1056/NEJM200003023420906
  61. Pollak L, Mehta SK, Pierson DL, Sacagiu T, Avneri Kalmanovich S, Cohrs RJ. Varicella-zoster DNA in saliva of patients with meningoencephalitis: a preliminary study. Acta Neurol Scand 2015; 131: 417-21. https://doi.org/10.1111/ane.12335
  62. Yamada S, Atsuta N, Tokunaga S, Motegi Y. Ipsilateral truncal sensory deficit in a patient with ophthalmic zoster sine herpete. Neurology 2003; 60: 1049-50.
  63. Mantero V, De Toni Franceschini L, Lillia N, Guccione A, Santilli I, Agostoni E. Varicella-zoster meningoencephaloradiculoneuropathy in an immunocompetent young woman. J Clin Virol 2013; 57: 361-2. https://doi.org/10.1016/j.jcv.2013.04.006
  64. Spagnoli C, Cantalupo G, Piccolo B, Cerasti D, Pisani F. Unusual trigeminal autonomic pain heralding hemichorea due to zoster sine Herpete vasculopathy. Pediatr Neurol 2013; 49: 205-8. https://doi.org/10.1016/j.pediatrneurol.2013.04.003
  65. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol 2009; 46: 249-53. https://doi.org/10.1016/j.jcv.2009.07.014
  66. Dueland AN, Devlin M, Martin JR, Mahalingam R, Cohrs R, Manz H, et al. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol 1991; 29: 569-72. https://doi.org/10.1002/ana.410290520
  67. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001; 125: 770-80. https://doi.org/10.5858/2001-125-0770-VZVIOT
  68. Philip A, Thakur R. Post herpetic neuralgia. J Palliat Med 2011; 14: 765-73. https://doi.org/10.1089/jpm.2011.9685
  69. Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, et al. Post-herpetic neuralgia: a review. Curr Pain Headache Rep 2016; 20: 17. https://doi.org/10.1007/s11916-016-0548-x
  70. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1-30.
  71. Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep 2018; 67: 103-8. https://doi.org/10.15585/mmwr.mm6703a5
  72. Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis 2019; 69: 341-4. https://doi.org/10.1093/cid/ciy953
  73. Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol 2013; 14: 77-85. https://doi.org/10.1007/s40257-013-0011-2
  74. Hui F, Boyle E, Vayda E, Glazier RH. A randomized controlled trial of a multifaceted integrated complementary-alternative therapy for chronic herpes zoster-related pain. Altern Med Rev 2012; 17: 57-68.
  75. Abdel-Aziz M, Azab NA, Khalifa B, Rashed M, Naguib N. The association of Varicella zoster virus reactivation with Bell's palsy in children. Int J Pediatr Otorhinolaryngol 2015; 79: 328-31. https://doi.org/10.1016/j.ijporl.2014.12.010
  76. Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med 2011; 123: 134-42. https://doi.org/10.3810/pgm.2011.09.2469
  77. Schlereth T, Heiland A, Breimhorst M, Fechir M, Kern U, Magerl W, et al. Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain 2015; 19: 193-201. https://doi.org/10.1002/ejp.537
  78. McCarberg B. Managing the comorbidities of postherpetic neuralgia. J Am Acad Nurse Pract 2003; 15(12 Suppl): 16-21.
  79. Cao S, Li Y, Deng W, Qin B, Zhang Y, Xie P, et al. Local brain activity differences between herpes zoster and postherpetic neuralgia patients: a resting-state functional MRI study. Pain Physician 2017; 20: E687-99.
  80. Cao S, Qin B, Zhang Y, Yuan J, Fu B, Xie P, et al. Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change. Am J Transl Res 2018; 10: 184-99.
  81. Cao S, Song G, Zhang Y, Xie P, Tu Y, Li Y, et al. Abnormal local brain activity beyond the pain matrix in postherpetic neuralgia patients: a resting-state functional MRI study. Pain Physician 2017; 20: E303-14.

Cited by

  1. Zoster sine herpete: a disease that ophthalmologists should be aware of vol.33, pp.4, 2020, https://doi.org/10.3344/kjp.2020.33.4.403
  2. The Neurotropic Varicella Zoster Virus: a Case of Isolated Abducens Nerve Palsy without Skin Rash in a Young Healthy Woman vol.29, pp.3, 2021, https://doi.org/10.1080/09273972.2021.1948073
  3. Diagnosis and management of ophthalmic zoster sine herpete accompanied by cervical spine disc protrusion: A case report vol.9, pp.25, 2020, https://doi.org/10.12998/wjcc.v9.i25.7588
  4. Dorsal root ganglion stimulation combined with spinal cord stimulation for effective treatment of postherpetic neuralgia - A case report - vol.16, pp.4, 2020, https://doi.org/10.17085/apm.21032